Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Cheddar Afternoon News Briefings of April 13th
Cheddar Afternoon News Briefings
Afternoon Alexa Flash Briefings of April 13th
Afternoon Alexa Flash Briefings
Warner Announces 'Game of Thrones' Prequel, 'Harry Potter' Series & New Platform Name
Warner Announces 'Game of Thrones' Prequel, 'Harry Potter' Series & New Platform Name
Warren Buffett Says More Bank Failures to Come
Warren Buffett Says More Bank Failures to Come
Whole Foods Closes Flagship San Francisco Location Over Safety Concerns
Whole Foods Closes Flagship San Francisco Location Over Safety Concerns
MLB Teams Extend Sale of Beers as Games Shorten in Rule Change
MLB Teams Extend Sale of Beers as Games Shorten in Rule Change
Wall Street Rallies and Tech Stocks Leap as Inflation Cools
A rally on Wall Street lifted stocks to their highest level in almost two months following the latest sign that inflation continues to cool.
US Wholesale Inflation Pressures Eased Sharply Last Month
U.S. wholesale prices fell last month, a sign that inflationary pressures in the economy are easing more than a year after the Federal Reserve began aggressively raising interest rates.
Morning Alexa Flash Briefings of April 13th
Morning Alexa Flash Briefings
